i3 Winners 2016

From Left to Right: Mr. Deep Kapuria, Chairman, The Hi-Tech Group & Board Member, Global Innovation & Technology Alliance (GITA), Mr. Y.S Chowdary, Hon’ble Minister of State for Science and Technology and Earth Sciences, Prof Anil Sahasrabudhe, Chairman, All India Council for Technical Education (AICTE) and Mr. Pravin Anand, Managing Partner, Anand & Anand releasing the India Innovation Initiative Report 2016 at the Awards Ceremony in New Delhi.

The audience at the 8th India Innovation Initiative Awards Ceremony 2016 in New Delhi.

Vikram Goel: i3 Platinum Award for Best Innovator

Title of the Innovation: Catheter Reprocessing System

Catheter Reprocessing System (CRS) is an angiography/angioplasty catheter cleaning machine. It is a fully automatic computer guided system with inbuilt self-testing and calibration with guaranteed cleaning.
CRS is a cost effective & quality assured way of reprocessing catheter. It also reduces infection and eliminates human error.
CRS can save millions of lives by making healthcare affordable and accessible for all sections of society. It  reduces
overall treatment cost up to 55%. This will especially benefit economic weaker sections of the  society.
CRS is as per the vision of Sh. NarenderModJi(PrimeMinister)and has followingbenefits:

• Affordable Treatment: Safe, Affordable & Accessibletreatment for economically  weakpeople.
• Make In India: 100% make in India  & indigenouslydeveloped.
• Swach Bharat Abhiyan:Creating less medical waste, morere-use and safedisposal.
• Reduces import of catheter by 90%.
• Eco-FriendlyandGreen Technology.

Yogeeswari Perumal: i3 Gold Award for Best Innovator

Title of the Innovation: Novel Drug Candidate For The Treatment of Breast Cancer Including The Triple Negative Type

Breast cancer is the MOST COMMON CANCER in women all over India and accounts for 25% to 31% of all cancers in women globally. Approximately 15% of all breast cancers are diagnosed as triple negative breast cancer (TNBC)- an aggressivesubtype.CurrentlyTNBChasnotreatmentoptionexceptchemotherapy andsurgery.

In our recent study, we have identified a therapeutic target, a lysosomal protease expressed not only in ER/PR positive, HER negative cell lines, but also in triple negative breast cancer cell lines. With this in place, we had identified promising drug candidates effective as lysosomal protease inhibitors with promising anticancer profile in a panel of breast cancer cell lines including TNBC cells. Further the candidate drugs exhibited antiangiogenic properties tested in-vivo in a zebra fishmodel.

Gaurav Mittal and Shashwat Ranjan Jena: i3 Silver Award for Best Innovator

Title of the Innovation: Greenvillips Vintage

Utilization of waste for producing somethingv aluable is one of the principles of Green&Sustainable Technology. Our process deals with utilizing industrial waste for production of Nanocellulose. Nanocellulose has remarkable properties and enormous applications in various sectors ofindustries.
The process designed is innovative,green and sustainable.It utilizes crudeglycerol from industries. It is a by-product of Biodiesel process. Supply of glycerol is high and the demand is low leading to problem of its disposal.

The process incorporates bacteria to consume this industrial waste and synthesize Nanocellulose as fermentation product. All the process parameters are specifically studied, monitored and designed for higher yield. The resultant Nanocellulose has high purity and applications. We also have a downstream technology for purification of the produced Nanocellulose and converting the Nanocellulose to aerogel. This aerogels are successfully tested as membranes for air purification applications  in  ourprototype